Risk factors for healthcare-associated candidemia in adults hospitalized with SARS-CoV-2 infection
- PMID: 38721496
- PMCID: PMC11077599
- DOI: 10.1017/ash.2024.25
Risk factors for healthcare-associated candidemia in adults hospitalized with SARS-CoV-2 infection
Abstract
Analyzing data from a national deidentified electronic health record-based data set using a matched case-control study design, we found that antibiotic use and severity of illness were independent risk factors for healthcare-associated candidemia in adult patients hospitalized with SARS-CoV-2 infection. Interleukin-6 inhibitor and corticosteroid use were not independent risk factors.
© The Author(s) 2024.
Conflict of interest statement
All authors report no commercial or other association that might pose a conflict of interest.
References
-
- Mastrangelo A, Germinario BN, Ferrante M, et al. Candidemia in coronavirus disease 2019 (COVID-19) patients: incidence and characteristics in a prospective cohort compared with historical non-COVID-19 controls. Clin Infect Dis: An Official Publication of the Infectious Diseases Society of America 2021;73:e2838–e9. - PMC - PubMed
-
- Seagle EE, Jackson BR, Lockhart SR, et al. The landscape of candidemia during the coronavirus disease 2019 (COVID-19) pandemic. Clin Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2022;74:802–811. - PubMed
LinkOut - more resources
Full Text Sources